Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Been under the radar, and remains under the radar... one day that will change!
Interesting paragraph in the RNS.
During the first half of 2023 the OrthoPure XT product continued to gain adoption in our current EU markets. We continued to address the global interest in the OrthoPure XT, the only non-human biologic option for certain anterior cruciate ligament reconstruction procedures. In the period, we announced the signing of an UK distributor and distribution agreements for China and Australia which will require additional regulatory and clinical approvals. To support the adoption of this novel product we are preparing a manuscript on the five-year clinical results from the OrthoPure XT trial which will be submitted to a noted European orthopaedic journal for publication.
So these Chinese and Australia Distribution agreements haven’t kicked off yet, this should provide significant growth once all approved.
I’m surprised we TRX are not sat with a significantly higher MCap lots of positive news these last 12 months which should’ve been rewarded more.
Delighted to see continuing progress, growth and innovation. Looking forward to the investor meet later today...well worth attending in my experience.
Very pleased with these results. Congrats to all at TRX.
All great news this morning!!!
Back in the black and a new product line ... What's not to like? LH&K Mafuta
Good set of results, not sure how market will react..... very happy to hold and build when possible. GLA
Wow, this is far better than I'd hoped for - and I think you're all right when you say the SP will drop on the back of some fantastic news. That said, if it did result in it being worth multiples of 50p I'm happy to wait!
When you read what TRX's critics say about the product, the main criticism is always around lack of profitability, not the product itself. It would be interesting to see their response to today's news.
GLALTH
Gin
Rns looks ok to me. Going back to bed..
Yes super progress and as you say new product which aims at a part of the market where there is great demand.
Who knows re the market today but at some point this company will be properly recognised for what it is, in my view - a gem.
Looking good , but I agree , market will kick us as per usual no doubt , hopefully not. Just need the new facility to be built asap to propel this further. Patience , but one day this will be multiples of 50p.
Excellent results! And I would expect a bounce today as this has been in a tight range for a while now. Fingers crossed.
Oh and another new product launch - brilliant!
Great! So I guess the market won't like that but hey....
I cannot foresee anything negative tomorrow ... But we all may need to wait before the masses catch on ... LH&K Mafuta
You just need patience.
Here is a statement from the July Half-Year Trading Update:
"Trading in the first half of 2023 was strong and in line with the Board's expectations. Group revenues for the Period are expected to be approximately $14.1 million, representing a 19% increase from the prior year and setting a record high for the Group. Furthermore, this performance marks the sixth consecutive reporting period of growth for the Group. As a result, the Board remains confident that the Group is on track to meet its expectations for the full year."
I am confident in the long-term prospects of this company and my investment in it.
I no longer have wonderful dreams but instead get nightmares as to why I ever got into shares and stock markets. I still think the results will be ok.....
Brought a smile to my face when I read your entry. I have had some terrible moments with aim shares and given the odd performance of the share price here I totally understand why you had your nightmare! As stated by others below I hope floundering SP purely reflects lack of profitability with its potential ignored for the time being due to current difficult markets. So hopefully market just ignoring future potential as against current but reducing losses and nothing else!
Would settle for 15% plus growth with more detail around when new distribution agreements are likely to come on line and also estimates of costs involved in future expansion plans.
Hope we all sleep well tomorrow night
I don't think I've every had a dream about a company before, but last night I dreamed that this one totally crashed. I don't believe in fate, so let's put it down to too much wine, and fingers crossed for tomorrow!
They gave a reasonable indication of the result expectation in the Update of 17 July 2023, so nothing drastic should be expected.... news on China would help and what cost outlay may be needed to stock these new partners
plus : March 2023 " For the avoidance of doubt, there is no present intention to raise any equity capital or issue any further shares in relation to our growth plans as Tissue Regenix is more than adequately funded to execute on its strategy."
Share may prove to have been oversold from which the Interims Update and media interviews could then show a boost ...
I too have a sizeable holding and the share price is frustrating. However, it is a small, loss making company, with a negative cashflow and it has debt. Despite what we might think about prospects and management delivery to date, these characteristics weigh more heavily in the current market. Also, its size makes it very tough for a new II to take a position. I expect a number of PIs have also just got bored and moved on. Hopefully the Tuesday update will give some fresh life to the SP.
Sell has dropped to 49p and even at that price you can only sell a small amount
Someone has been consistently selling over the past couple of weeks with lots of tiny inconsequential buys - I am a big holder here so hope this is just someone selling out their holding have lost patience - we’ll know Tuesday
Correlation ≠ causation.
The share price will rise when the company is cash generative, or looks about to be. At present (last year's results) it's still burning through its cash reserves.
It seems that for some reason share consolidation kills the SP.
Its still not topped the consolidation price of 60p and has now fallen to 51p.
The same thing has happened at ITX in a much more recent share consolidation.
Hopefully the results will reverse the trend but I am not hopeful - it seems the algorithms are stacked against consolidation to encourage trading on the downside.
I agree ... TRX is a bit of an enigma ... Everything is lining up nicely but the share price is relatively static ... Guess we will just have to wait it out. LH&K Mafuta